Serum creatinine/cystatin C ratio is a surrogate marker for sarcopenia in patients with idiopathic pulmonary fibrosis
K Fujita, H Ohkubo, A Nakano, N Takeda… - BMC pulmonary …, 2022 - Springer
… Cr/CysC ratio may be a surrogate marker of sarcopenia in patients with IPF. Furthermore, it is
… determine whether the Cr/CysC ratio can be used to detect sarcopenia in patients with IPF. …
… determine whether the Cr/CysC ratio can be used to detect sarcopenia in patients with IPF. …
Serum creatinine/cystatin C ratio as a surrogate marker for sarcopenia in patients with gastric cancer
J Sun, H Yang, W Cai, J Zheng, N Shen, X Yang… - BMC …, 2022 - Springer
… surgical outcomes and long-term survival of patients with gastric cancer. Serum creatinine/…
as a surrogate marker for sarcopenia but has not been adequately studied in patients with …
as a surrogate marker for sarcopenia but has not been adequately studied in patients with …
Serum creatinine/cystatin C ratio as a surrogate marker for sarcopenia in patients with chronic obstructive pulmonary disease
K Hirai, A Tanaka, T Homma, Y Goto, K Akimoto, T Uno… - Clinical nutrition, 2021 - Elsevier
… Sarcopenia is common in patients with chronic obstructive pulmonary disease (COPD). … as
a surrogate marker for sarcopenia but has not been adequately studied in patients with COPD…
a surrogate marker for sarcopenia but has not been adequately studied in patients with COPD…
Decreased the creatinine to cystatin C ratio is a surrogate marker of sarcopenia in patients with type 2 diabetes
T Osaka, M Hamaguchi, Y Hashimoto… - Diabetes research and …, 2018 - Elsevier
… could be used as a surrogate marker for sarcopenia because Cre is affected … patients with
type 2 diabetes, we investigated the association between the Cre/CysC ratio and sarcopenia…
type 2 diabetes, we investigated the association between the Cre/CysC ratio and sarcopenia…
Psoas muscle analysis as a surrogate marker of sarcopenia and frailty: A multicenter analysis of predictive capacities over short-and long-term outcomes after …
R Vázquez Pérez, F Álvarez Marcos, C Tello Díaz… - …, 2023 - journals.sagepub.com
… Surrogate markers of sarcopenia had a poor predictive profile for postoperative mortality
after AAA repair in our sample. However, PMD stood out as an independent predictor of long-…
after AAA repair in our sample. However, PMD stood out as an independent predictor of long-…
L3 skeletal muscle index (L3SMI) is a surrogate marker of sarcopenia and frailty in non-small cell lung cancer patients
D Portal, L Hofstetter, I Eshed… - Cancer Management …, 2019 - Taylor & Francis
… (ALT) levels are accepted surrogate markers of sarcopenia and related frailty. We aimed
to evaluate the potential association of these markers with NSCLC patients’ survival. …
to evaluate the potential association of these markers with NSCLC patients’ survival. …
Comparison of different surrogate markers of muscle mass for the diagnosis of sarcopenia in patients with colorectal cancer
JL Li, Q Zhou, QW Wang, DC Luo… - Journal of Nutritional …, 2024 - journals.lww.com
… sarcopenia. Survival analyses, contingent on different surrogate markers of muscle mass and
sarcopenia… Results: We enrolled 815 patients with CRC (522 male and 293 female patients…
sarcopenia… Results: We enrolled 815 patients with CRC (522 male and 293 female patients…
Hemoglobin levels as a surrogate marker of sarcopenia in patients with liver cirrhosis
A Shibamoto, T Namisaki, J Suzuki, T Kubo… - Hepatology …, 2023 - Wiley Online Library
… This study aimed to elucidate a surrogate marker of sarcopenia in patients with liver … with
sarcopenia and could be a useful surrogate marker to predict sarcopenia in patients with LC. …
sarcopenia and could be a useful surrogate marker to predict sarcopenia in patients with LC. …
Morphologic change of the psoas muscle as a surrogate marker of sarcopenia and predictor of complications after colorectal cancer surgery
M Hanaoka, M Yasuno, M Ishiguro, S Yamauchi… - International journal of …, 2017 - Springer
… The aim of this study was to investigate whether MPM status could be used as (a) a surrogate
marker of sarcopenia in CRC patients and (b) a preoperative predictor of complications …
marker of sarcopenia in CRC patients and (b) a preoperative predictor of complications …
Fat-free mass index as a surrogate marker of appendicular skeletal muscle mass index for low muscle mass screening in sarcopenia
R Kawakami, K Tanisawa, T Ito, C Usui… - Journal of the American …, 2022 - Elsevier
… the suitability of BIA-measured FFMI as a simple surrogate marker of the ASMI and
calculated the optimal FFMI cutoff value for low muscle mass screening to diagnose sarcopenia. …
calculated the optimal FFMI cutoff value for low muscle mass screening to diagnose sarcopenia. …
相关搜索
- cell lung cancer patients surrogate marker
- idiopathic pulmonary fibrosis sarcopenia in patients
- liver cirrhosis sarcopenia in patients
- sarcopenia and frailty surrogate marker
- surrogate marker of muscle mass
- meta analysis sarcopenia in patients
- gastric cancer surrogate marker for sarcopenia
- systemic marker sarcopenia in patients
- morphologic change surrogate marker of sarcopenia
- simple markers sarcopenia in patients
- cystatin c ratio sarcopenia in patients
- complete resection sarcopenia in patients
- serum creatinine sarcopenia in patients
- risk factors sarcopenia in patients
- predictive capacities surrogate marker of sarcopenia
- multicenter analysis surrogate marker of sarcopenia